Achim Kless | Senior Director Pain Genetics
Eli Lilly and Company

Dr. Achim Kless is Senior Director of Pain Genetics at Eli Lilly, with extensive expertise 
in research leadership and drug development strategy. He has spearheaded biomarker research programs, 
medical publications, and global collaborations, effectively bridging pharma, CROs, and academic institutions. 
Skilled in genetics, scientific computing, and translational medicine, he has advanced novel approaches for 
pain research while ensuring high-quality, resource-efficient outcomes. Achim is driven by a passion for exceeding 
expectations and creating impactful solutions that address critical unmet needs in neuroscience.